Urinalysis Market Report 2026

The urinalysis market size has grown strongly in recent years. It will grow from $3.82 billion in 2025 to $4.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing prevalence of diabetes and kidney diseases, expansion of clinical diagnostic laboratories, rising demand for routine health screening, increased adoption of laboratory automation, improved availability of consumables.

The urinalysis market size is expected to see strong growth in the next few years. It will grow to $5.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic testing, rising focus on preventive healthcare, expansion of home healthcare diagnostics, growing integration of ai-based interpretation tools, increasing healthcare spending on diagnostics. Major trends in the forecast period include increasing adoption of automated urinalysis analyzers, rising use of point-of-care testing kits, growing integration of digital result management, expansion of home-based urinalysis testing, enhanced focus on diagnostic accuracy.

The rising prevalence of chronic kidney disease is expected to drive the growth of the urinalysis market going forward. Chronic kidney disease (CKD) is a medical condition in which the kidneys are damaged and lose their ability to filter waste and excess fluids from the blood effectively. The increasing prevalence of CKD is largely attributed to higher rates of diabetes, which over time can impair kidney function. Urinalysis plays a critical role in detecting early signs of kidney disease by identifying abnormalities in urine, such as protein, blood, or waste imbalances, that indicate declining kidney function. For example, in June 2023, publications by Oxford University Press, a UK-based department of the University of Oxford, reported that the prevalence of CKD in the UK is projected to increase by 4%, rising from 8.27 million to 8.61 million individuals between 2022 and 2032. Therefore, the growing prevalence of chronic kidney disease is fueling the expansion of the urinalysis market.

Key companies in the urinalysis market are focusing on developing advanced products, such as urine particle analyzers, to maintain a competitive advantage. Urine particle analyzers are clinical devices designed for automated urine testing, capable of detecting and quantifying multiple analytes. They offer greater accuracy and precision compared to manual microscopy, standardizing urine particle analysis and reducing inter-observer variability. For instance, in April 2023, Sysmex Europe SE, a Germany-based provider of automated in vitro diagnostics, launched the UF-1500 Fully Automated Urine Particle Analyzer. This system is engineered to reduce its footprint by approximately 30% while maintaining high performance and usability. It utilizes advanced fluorescence flow cytometry technology, similar to the UF-5000, and caters to a range of customer needs, including fully automated urinalysis workstations for both developed and emerging markets, as well as backup and satellite systems for facilities already using the UN-Series. It also supports connectivity to UC-3500 urine chemistry analyzers.

In July 2023, LGC Clinical Diagnostics, a UK-based diagnostics and life sciences company, acquired Kova International Inc. for an undisclosed amount. Through this acquisition, LGC aims to enhance its clinical quality control and in-vitro diagnostics portfolio by incorporating Kova’s urinalysis and toxicology quality control products used in clinical laboratories. Kova International Inc. is a US-based manufacturer of in-vitro urinalysis and toxicology control materials.

Major companies operating in the urinalysis market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health Inc., Abbott Laboratories, Danaher Corporation, Beckman Coulter Inc., Sysmex Corporation, ARKRAY Inc., ACON Laboratories Inc., Bio-Rad Laboratories Inc., URIT Medical Electronic Group Co Ltd., 77 Elektronika Kft, Thermo Fisher Scientific Inc., Teco Diagnostics, Mindray Medical International Limited, Quidel Corporation, Becton Dickinson and Company, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Guangzhou Wondfo Biotech Co. Ltd., Chembio Diagnostic Systems Inc.

North America was the largest region in the urinalysis market in 2025. The regions covered in the urinalysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urinalysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the urinalysis market by increasing costs of imported diagnostic instruments, reagents, test strips, sensors, and electronic components used in automated analyzers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces cost pressure on consumables manufacturing. These tariffs are raising testing costs and slowing equipment upgrades. However, they are also supporting local reagent production, regional instrument assembly, and innovation in cost-effective diagnostic solutions.

The urinalysis market research report is one of a series of new reports that provides urinalysis market statistics, including urinalysis industry global market size, regional shares, competitors with a urinalysis market share, detailed urinalysis market segments, market trends and opportunities, and any further data you may need to thrive in the urinalysis industry. This urinalysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A urinalysis, commonly known as a urine test, evaluates the visual, chemical, and microscopic characteristics of urine. It examines the appearance, concentration, and content of urine and includes various tests that detect and measure compounds excreted in urine using a single sample. Urinalysis is used to diagnose and manage a range of conditions, including diabetes, kidney disease, and urogenital infections.

The main types of urinalysis tests include pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. Pregnancy and fertility tests are designed to detect a specific hormone in blood or urine to determine pregnancy. These tests measure hCG, a hormone produced during pregnancy, which can confirm pregnancy and assist couples in family planning, regardless of whether they intend to conceive. The process involves products such as consumables and instruments, applied in conditions including urinary tract infections (UTIs), kidney disease, liver disease, diabetes, hypertension, and others. These tests are utilized by diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories and institutes.

The urinalysis market consists of revenues earned by entities by providing urinalysis services by providing visual exam of urine, dipstick test, screening tests, reagents test, culture test and microscopic exam of urine. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinalysis market also includes sales of automated urine analyzers, point of care analyzers, integrated urine analyzers, strip reader connect system equipment which are used in providing urinalysis services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.